TC BANCSHARES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TC Bancshares, Inc.
If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/otc-tcbc/ to learn more.
To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
Kforce Inc (KFRC) Q2 2025 Earnings Call Highlights: Navigating Revenue Decline with Strategic ...
Total Revenue: $334.3 million, a decline of 6.2% year over year. Earnings Per Share (EPS): $0.59, consistent with expectations. Gross Margin: Increased 40 basis points sequentially to 27.1%. Flex Revenue: Sequential growth in Technology and Finance and Accounting businesses. Direct Hire Revenue: Challenged and below expectations, representing approximately 2% of overall revenues. Average Bill Rate in Technology: $90, stable over the past three years. Average Bill Rate in Finance and Accounting: Approximately $54 per hour, improved sequentially and year over year. SG&A Expenses: 22.2% of revenue, increased 40 basis points year over year. Operating Margin: 4.5%. Effective Tax Rate: 24.6% for the second quarter. Capital Returned to Shareholders: $17.4 million through dividends and share repurchases. Operating Cash Flows: $18.4 million. Return on Equity: Exceeds 30%. Net Debt Levels: Approximately $67.5 million. Q3 Revenue Guidance: Expected to be in the range of $324 million to $332 million. Q3 EPS Guidance: Expected to be between $0.53 and $0.61. Warning! GuruFocus has detected 3 Warning Signs with KFRC. Release Date: July 28, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Kforce Inc (NYSE:KFRC) reported sequential flex revenue growth in both technology and finance and accounting businesses, indicating resilience in a challenging macroeconomic environment. The company is well-positioned to capitalize on the increasing demand for AI foundational readiness work, leveraging its expertise in technology and access to evolving skill sets. Kforce Inc (NYSE:KFRC) has successfully shifted towards consulting-oriented solutions, which have shown strong demand and contributed to stable margins and average bill rates. The company's development center in Pune enhances its ability to provide cost-effective solutions through a blended onshore, nearshore, and offshore model. Kforce Inc (NYSE:KFRC) has a strong client base, predominantly consisting of large, market-leading companies, which supports its long-term above-market performance. Negative Points Total revenues declined 6.2% year over year, with direct hire revenues particularly challenged due to macroeconomic conditions. The company experienced some unanticipated project ends, leading to a modest sequential decline expected in the technology business for Q3. Flex revenues in the finance and accounting business, although showing sequential growth, declined 16.8% year over year. Overall gross margins declined 70 basis points year over year due to higher healthcare costs and a lower mix of direct hire revenues. SG&A expenses as a percentage of revenue increased 40 basis points year over year, driven by deleverage from lower revenue levels and higher healthcare costs. Q & A Highlights Q: Can you discuss the levels of discussion around AI projects and when you expect demand to increase significantly? A: Joseph Liberatore, President and CEO, explained that most organizations are in the preparation phase for AI, focusing on foundational readiness in governance, data, cloud, and security. Only about 10% of organizations are fully equipped to leverage AI, mostly in the technology sector. There is significant opportunity in data organization and digital modernization, which will prepare companies to leverage AI in the future. Q: What is causing the early project ends in Tech Flex, and do you expect these projects to resume? A: David Kelly, Chief Operating Officer, noted that some projects ended unexpectedly due to clients reallocating investments to other technology projects. This was not a reduction in technology spend but a shift in focus. Despite these ends, the overall sentiment is stability, with consistent new assignments and project wins. Q: How would you characterize the current pipeline, and are companies holding off on legacy projects due to AI uncertainties? A: David Kelly stated that the pipeline remains strong, particularly in data and digital areas. Companies are not holding off on legacy projects due to AI but are looking for immediate returns amidst economic uncertainty. AI preparation involves years of work, and companies cannot afford to wait. Q: What has driven the sequential growth in the Finance and Accounting (FA) business, and is the repositioning complete? A: David Kelly highlighted the team's focus on higher skill sets and an executable model, moving away from administrative FA work. The average bill rate is now in the mid-50s, aligning with client needs. The repositioning appears complete, with recent sequential growth indicating stabilization. Q: Can you provide more details on the impact of nearshore and offshore dynamics on margins and hourly rates? A: David Kelly mentioned that while the nearshore and offshore presence is slightly accretive to margins, it is not yet significant enough to impact overall bill rates or margins. The focus is on supporting U.S. revenue, and the consulting-oriented engagements contribute to stability in bill rates and margins. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
24 minutes ago
- Yahoo
Income Investors' Guide to Dynex Capital's (DX) Highest Dividend Potential
Dynex Capital, Inc. (NYSE:DX) is included among the 10 Stocks with Highest Dividend to Buy Right Now. Aerial shot of a modern skyline with REIT building projects in downtown. Dynex Capital, Inc. (NYSE:DX) is an internally managed mortgage REIT that focuses on investing in residential and commercial mortgage-backed securities using leverage. In its Q2 earnings report, the company posted a rise in economic net interest income and a reduction in derivative losses, despite ongoing market volatility. Co-CEO and President Smriti Laxman Popenoe noted that Dynex Capital, Inc. (NYSE:DX)'s disciplined approach to raising and allocating capital in attractive mortgage-backed securities markets positions the firm to deliver strong returns. She added that the company remains committed to investing in liquid, transparent, and easily valued assets, which supports its risk management strategy across varying economic and interest rate conditions. Dynex Capital, Inc. (NYSE:DX) is one of the best stocks with the highest dividend, as the company has been rewarding shareholders with consistent dividends since 2008. Currently, the company offers a monthly dividend of $0.17 per share for a dividend yield of 16%, as of July 27. While we acknowledge the potential of DX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Sign in to access your portfolio
Yahoo
33 minutes ago
- Yahoo
Revvity Inc (RVTY) Q2 2025 Earnings Call Highlights: Strong Software Growth and Strategic Share ...
Revenue: $720 million in Q2, 3% organic growth. Adjusted EPS: $1.18, above expectations. Life Sciences Segment Growth: 4% organic growth. Diagnostics Segment Growth: 2% organic growth. Signals Software Growth: Over 30% organic growth. Free Cash Flow: $115 million in Q2, 83% conversion of adjusted net income. Operating Margin: 26.6% adjusted operating margin, down 210 basis points year over year. Share Repurchase: $293 million worth of shares repurchased in Q2. Full-Year Organic Growth Outlook: 2% to 4% range. Full-Year Adjusted EPS Outlook: $4.85 to $4.95. Net-Debt-to-Adjusted-EBITDA Ratio: 2.6 times. Adjusted Tax Rate: 19.1% in Q2. Warning! GuruFocus has detected 5 Warning Signs with RVTY. Release Date: July 28, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Revvity Inc (NYSE:RVTY) achieved 3% organic growth in Q2 2025, in line with expectations, driven by strong performance in the Life Sciences segment. The Signals Software franchise experienced approximately 30% growth, setting a new record for orders in a single quarter. Revvity Inc (NYSE:RVTY) reported adjusted EPS of $1.18, which was above expectations and guidance. The company generated $115 million in free cash flow during the quarter, maintaining a solid 90% conversion rate year-to-date. Revvity Inc (NYSE:RVTY) repurchased nearly $300 million worth of stock in Q2, bringing total repurchases to nearly $450 million for the first half of the year. Negative Points The Diagnostics segment faced challenges in China due to changes in hospital lab reimbursement policies, impacting the Immunodiagnostics business. Revvity Inc (NYSE:RVTY) lowered its full-year organic growth outlook to 2% to 4%, down 1% from prior expectations. The company anticipates a meaningful pullback in its Immunodiagnostics business in China for the remainder of the year. Operating margins were pressured by lower volumes of high-margin diagnostic tests and recent changes in FX rates. The academic and government customer segment continued to show weakness, with revenue declining in the low single digits year over year. Q & A Highlights Q: Can you explain the guidance change related to organic growth, particularly in China, and whether other factors like VBP are involved? A: (Prahlad Singh, CEO) The majority of the impact is from the DRG policy in China, which affects multiplex tests. This policy reduces test volumes, but in the long term, it may lead to more single-plex tests, which are more expensive. We are working with stakeholders to potentially reverse these changes due to their impact on patient care. Q: Regarding margin changes, what are your expectations for 2026 margins, and what growth assumptions are they based on? A: (Maxwell Krakowiak, CFO) We expect a baseline operating margin of 28% for 2026, with margin expansion depending on organic growth levels. Typically, with high single-digit growth, we expect a 75 basis point margin expansion, and with mid-single-digit growth, about 50 basis points. Q: What are the revenue pacing assumptions for this year, and how do you see the impact of NIH funding and year-end budget flush? A: (Maxwell Krakowiak, CFO) We expect normal seasonality with a high single-digit ramp in both Life Sciences and Diagnostics. The fourth quarter will see a ramp-up in gel and larger volume in Signals Software. We assume academic and government funding will remain weak for the rest of the year. Q: Can you provide insights into the Life Sciences segment's performance, particularly reagents and instruments, and any guidance changes? A: (Prahlad Singh, CEO) Pharma-biotech showed stability with mid-single-digit growth, and our Life Sciences reagents business has grown for five consecutive quarters. While capital equipment spending is impacted, we remain optimistic about the reagents business. Q: How is the Software segment performing, and what are the expectations for growth in the second half? A: (Prahlad Singh, CEO) The Signals Software business had a record quarter with 32% organic growth. We focus on net retention, ARR, and APV, with strong SaaS bookings. We expect continued growth due to investments and new product launches. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
